ImageneBio (IMA) Return on Sales (2020 - 2025)

ImageneBio has disclosed Return on Sales across 6 years of filings, most recently posting 0.08% for Q1 2025.

• Return on Sales for Q1 2025 came in at 0.08%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2025 was 0.07% (changed N/A YoY), and the FY2023 annual result was 0.07%, down 3.0% from the prior year.
• Return on Sales came in at 0.08% for Q1 2025 at ImageneBio, down from 0.01% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q4 2021 to a low of 0.54% in Q2 2022.
• The 5-year median for Return on Sales is 0.04% (2021), against an average of 0.1%.
• Across the five-year window, Return on Sales surged 401 bps in 2021 and plunged 50 bps in 2022, its largest moves.
• ImageneBio's Return on Sales stood at 0.0% in 2021, then plunged by 1970 bps to 0.03% in 2022, then tumbled by 1053 bps to 0.3% in 2023, then soared by 97 bps to 0.01% in 2024, then slumped by 739 bps to 0.08% in 2025.
• The last three Return on Sales figures came in at 0.08% (Q1 2025), 0.01% (Q3 2024), and 0.3% (Q4 2023), per Business Quant data.